Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pierre-François Laterre and Jean-Louis Vincent.
Pierre-François Laterre
Connection Strength
0.090
Jean-Louis Vincent
  1. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care. 2017 08 15; 21(1):213.
    View in: PubMed
    Score: 0.046
  2. A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. Crit Care. 2017 02 04; 21(1):22.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.